Figure 6.
24hr kaolin intake (A), chow intake (B), and body weight change (C) following an acute intraparenchymal CeA administration of exendin-4 (0.05μg/100nl) or vehicle. In a two-bottle CTA learning paradigm, CeA administration of exendin-4 produced a CTA when compared to vehicle injections (D). Data are mean ± SEM, * = p < 0.05 vs. vehicle.